Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study

Table 5 Odds ratios of MetS at baseline and longitudinal status change in MetS for new onset of type 2 diabetes

	MetS-INT		MetS-JP
	Model 1	Model 2^a	Model 1	Model 2^b
MetS at baseline	3.46^** (2.02–5.91)	1.49 (0.82–2.69)	5.15^** (2.60–10.20)	3.45^** (1.68–7.05)

	Model 1	Model 2^a	Model 1	Model 2^b
Non-MetS to non-MetS	1.00	1.00	1.00	1.00
Non-MetS to MetS	4.86^** (2.44–9.70)	4.16^** (2.03–8.53)	4.28^** (2.27–8.08)	4.11^** (2.08–8.13)
MetS to non-MetS	4.97^** (1.89–13.07)	1.75 (0.63–4.89)	3.06 (0.95–9.87)	0.93 (0.25–3.48)
MetS to MetS	7.50^** (3.67–15.33)	3.38^** (1.57–7.25)	15.55^** (6.71–36.07)	6.64^** (2.46–17.89)

Model 1 adjusted for age, sex
Model 2 Model 1 + FPG ≥100 mg/dl at baseline
Model 3 Model 1 + FPG ≥110 mg/dl at baseline
MetS-INT metabolic syndrome assessed by the interim criteria by 6 institutions, MetS-JP metabolic syndrome assessed by the Japanese criteria
* p < 0.05
** p < 0.01

ISSN: 1758-5996